Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.67 |
| ▸ | HPGD | P15428 | 4/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 5/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30251130 | 1.00 | MEN1 (0.67) | MEN1KMT2AALDH1A1L3MBTL1HPGD | |
| SCHEMBL26626360 | 0.97 | MEN1 (0.62) | MEN1KMT2AALDH1A1L3MBTL1HPGD | |
| SCHEMBL24212028 | 0.92 | MEN1 (0.61) | MEN1KMT2AALDH1A1L3MBTL1HPGD | |
| SCHEMBL22133385 | 0.92 | MEN1 (0.56) | MEN1KMT2AALDH1A1L3MBTL1HPGD | |
| SCHEMBL25649819 | 0.92 | ALDH1A1 (0.65) | MEN1KMT2AALDH1A1L3MBTL1HPGD | |
| SCHEMBL19301696 | 0.91 | ALDH1A1 (0.50) | MEN1KMT2AALDH1A1L3MBTL1HPGD | |
| SCHEMBL18463438 | 0.88 | ALDH1A1 (0.58) | MEN1KMT2AALDH1A1L3MBTL1HPGD | |
| SCHEMBL20690702 | 0.87 | MEN1 (0.48) | MEN1KMT2AALDH1A1L3MBTL1HPGD | |
| SCHEMBL14725231 | 0.86 | MAPT (0.54) | MEN1KMT2AALDH1A1L3MBTL1HPGD | |
| SCHEMBL17969965 | 0.86 | MEN1 (0.50) | MEN1KMT2AALDH1A1L3MBTL1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4600325-B1 | ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | SOLUS ADVANCED MATERIALS CO LTD (KR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4600325-A1 | ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | Solus Advanced Materials Co., Ltd. (KR) | 2025-08-13 | — | — | EP | disclosed |
| WO-2025135308-A1 | ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 솔루스첨단소재 주식회사 | 2025-06-26 | — | — | WO | disclosed |
| US-11787789-B2 | Compound for an organic electric element, an organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-11787789-B2 | Compound for an organic electric element, an organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-11205755-B2 | Compound for organic electronic element, organic electronic element using same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2021-12-21 | — | — | US | disclosed |
| US-20210171510-A1 | COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
| WO-2021029757-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2021-02-18 | — | — | WO | disclosed |
| US-20190229271-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT | DUK SAN NEOLUX CO., LTD. (KR) | 2019-07-25 | — | — | US | disclosed |
| US-20190189927-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2019-06-20 | — | — | US | disclosed |
| WO-2019022435-A1 | COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF | 덕산네오룩스 주식회사 | 2019-01-31 | — | — | WO | disclosed |
| WO-2018021737-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2018-02-01 | — | — | WO | disclosed |
| WO-2018012780-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRIC ELEMENT | 덕산네오룩스 주식회사 | 2018-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787789-B2 | Compound for an organic electric element, an organic electric element using the same, and an electronic device thereof | PIEZO1, ORAI2, OCIAD1 | MEN1 366/4885KMT2A 1455/4885ALDH1A1 957/4885 |
| US-20210171510-A1 | COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OCIAD1 | MEN1 366/4885KMT2A 1455/4885ALDH1A1 957/4885 |
| US-11205755-B2 | Compound for organic electronic element, organic electronic element using same, and electronic device thereof | PIEZO1, OR51E2, ORAI2 | MEN1 625/4885KMT2A 820/4885ALDH1A1 2676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.